Clinical Trial Update: 68Ga-HSA PET/CT Imaging for Protein-losing Enteropathy

View source ↗

Summary

A clinical trial evaluating 68Ga-HSA PET/CT imaging for protein-losing enteropathy, with cancer listed as the condition; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Protein-losing Enteropathy

Drugs mentioned

• 68Ga-HSA (Gallium-68 labeled human serum albumin)

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Cancer | Status: NOT_YET_RECRUITING